E19CSE013

EB11

VANSIKA SINGH

Topic Chosen – ErlySign

Early diagnosis, testing, and treatment have been shown to increase patient survival rates and wellbeing while also
lowering the cost and complexity of cancer therapy. Annually, up to 3.7 million lives can be saved by employing
resource-appropriate preventive, early diagnosis, and treatment measures. Over 11.5 lakh individuals are diagnosed
with cancer each year, and over 10% of Indians are at risk of acquiring cancer before the age of 75. According to a
recent research by Grand View Research, Inc., the worldwide cancer diagnostics market is anticipated to reach USD
249.6 billion by 2026, growing at a 7.0 percent CAGR over the forecast period. The market is being driven primarily
by the continuous development of novel products, as well as the growing demand for early detection of different
ailments.

It is expected that during the forecast period from 2021 to 2025, oral cancer diagnosis will increase significantly. In
2021, the market will grow steadily, and as major players increasingly adopt strategies, the market is expected to
exceed expectations. The increase in the incidence of oral cancer, the increase in health care expenditures and the
increase in risk factors such as age, and the rise of HPV16 are some of the factors driving the global oral cancer
treatment market. In addition, increasing tobacco consumption around the world is a major contributor to the oral
cancer treatment market. According to a report by the World Health Organization (WHO), global tobacco use is 4
million and it is increasing every year. By 2020, the number of tobacco-related deaths may reach 10 million. Another
important factor is the increasing amount of alcohol that causes oral cancer in the world. In turn, this may promote
the development of the global oral cancer treatment market. In addition, the increase in the number of patients and
the massive government investment in providing better oral cancer treatments are expected to drive the market
during the forecast period.

The increase in cancer incidence has created a need for these screening tests and imaging techniques to monitor
disease progression. Cancer research associations are contributing intensely on research tasks to dispatch
progressed indicative devices on the lookout, which are fit for diagnosing the illness much before the symptoms
show up. . The global prevalence of breast, ovarian and lung cancer is increasing, the elderly population and medical
expenditures are increasing, the improvement of the healthcare sector and the increasing demand for effective
screening tests are driving global sales growth. In addition, increasing funding for R&D activities and increasing
market participants' focus on developing more affordable and advanced diagnostic tests and kits are expected to
drive future market growth.

A test kit that can detect precancerous conditions even before a visible tumor or lesion appears in the Oral cavity,
Lip, Tongue, or Throat. A test kit which users can carry at home and can detect precancerous lesions before visible
tumors or lesions appear in the mouth, lips, tongue or throat can become a real turning point for early cancer
detection. It can save a lot of expenses that patients have to pay for cancer testing. In turn, this test kit can make a
lot of money because it is affordable for the general public.